Advocating for Better Cannabis Business Regulations

Complying with cannabis business regulations presents a challenge for start-ups and smaller firms. Corporate and regulatory attorneys often help clients understand and comply with complex regulations. This is especially true in the cannabis industry. In the United States, many industries lack well thought out regulatory policy. Some industries, like cannabis, suffer from over-regulation, overwhelming smaller

constitutional lawsuit end federal cannabis prohibition

Here We Go! The Latest Lawsuits to End Federal Prohibition

High profile lawsuits to end cannabis prohibition are nothing new. We’ve covered efforts going back several years, though none of these has succeeded. A recently announced attempt, though, may be the best chance yet– especially given the changing environment with cannabis legalization in so many states; and especially given Constitutional jurisprudence relevant to those changes.

canna law on the internet

Half-Truths and Canna Law on the Internet

When it comes to canna law on the internet, half-truths might be a bigger problem than outright lies or mistakes. Recently, our sister China Law Blog declared that China Law on the Internet Is All Wrong. As a lawyer who spends a lot of time working on China-related matters, I can confirm that there is

federal cannabis reform

Not All Cannabis Reform is a Good Thing

These days, everyone is throwing a hat into the ring of cannabis reform. Many ideas are floating around; some of them are not so hot. Last week’s federal legislative activity is a good example of this. Two things happened on the same day: the Senate unanimously passed the CMRE Act (Cannabidiol and Marihuana Research Expansion

oregon cannabis qualified applicant social equity

Oregon Cannabis: Social Equity and “Qualified Applicants”

Who is a “qualified applicant” under Oregon’s new marijuana license reassignment program? First, some context. House Bill 4016, which introduced the reassignment concept, represents a sea change for Oregon’s licensed marijuana industry. The bill presently awaits signature by the Governor, and no one is betting it won’t become law. Our take on all of Oregon’s

california cannabis taxes children

Would Cutting California Cannabis Taxes Hurt Children?

We have been watching the debate on California cannabis taxes, including the arguments from child welfare advocates that cannabis tax reductions would harm children. In this post, I’ll explain why this perspective is flawed, and propose a better path forward. The California cannabis tax headache California is potentially overhauling cannabis taxes, a much-needed reform for

mlk cannabis marijuana

MLK Day: Cannabis and Civil Rights

Happy MLK Day! If Martin Luther King Jr. were alive today, he would almost certainly advocate to end the War on Drugs. Dr. King never spoke publicly about drugs or cannabis in particular: he was assassinated in 1968, two years before President Nixon signed the Controlled Substances Act (CSA). But it is well established that

cannabis marijuana pun

Can We All Cool It with the Cannabis Puns Please?

I recently received a random marketing email in which I was greeted with the word “high” in place of the word “hi”. My first reaction was a long, visceral cringe. My second was the thought, “hey, if I – just a lowly cannabis industry lawyer and not an actual cannabis industry stakeholder – am so

dmt

DMT Therapy: Coming to a Clinic Near You?

DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back

psilocybin controlled substances act reschedule

A Strategy for Rescheduling Psilocybin

Public and scientific interest in psychedelics such as psilocybin and MDMA is expanding. Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Psilocybin, a